Jazz Pharmaceuticals to Acquire GW Pharma

In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.

The post Jazz Pharmaceuticals to Acquire GW Pharma appeared first on Cannabis Industry Journal.